Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
Comparison Of Minimal Residual Disease As Outcome Predictor For AML Patients In First Complete Remission Undergoing Myeloablative Or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation
Blood (2013)
  • Boglarka Gyurkocza, University of Washington
  • Barry E. Storer, Fred Hutchinson Cancer Research Center
  • John M. Pagel, University of Washington
  • Sarah A. Buckley, University of Washington
  • Mohamed L. Sorror, Fred Hutchinson Cancer Research Center
  • Colleen Delaney, University of Washington
  • Brent L. Wood, University of Washington
  • H. Joachim Deeg, University of Washington
  • Rainer Storb, Fred Hutchinson Cancer Research Center
  • Frederick R. Appelbaum, University of Washington
  • Brenda M. Sandmaier, Fred Hutchinson Cancer Research Center
Link
Disciplines
Publication Date
November 15, 2013
Citation Information
Boglarka Gyurkocza, Barry E. Storer, John M. Pagel, Sarah A. Buckley, et al.. "Comparison Of Minimal Residual Disease As Outcome Predictor For AML Patients In First Complete Remission Undergoing Myeloablative Or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation" Blood Vol. 122 Iss. 21 (2013) p. 1317 - 1317
Available at: http://works.bepress.com/john-pagel/120/